OTCMKTS:CRRVF CVR Medical (CRRVF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About CVR Medical Stock (OTCMKTS:CRRVF) Get CVR Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CVR Medical Corp (OTCMKTS:CRRVF) is a U.S.-based medical technology company specializing in the development and commercialization of proprietary gas-based insufflation systems for gastrointestinal procedures. The company’s platform technologies are designed to improve patient comfort and procedural efficiency during endoscopic interventions, with a primary focus on colonoscopy. CVR Medical’s products leverage hydrogen-based delivery to provide a low-residue, clean gas that can potentially reduce post-procedure discomfort and preparation time for patients. The company’s lead offering, the Clearway™ Hydrogen Insufflation System, has received 510(k) clearance from the U.S. Food and Drug Administration for use in colonoscopic procedures. CVR Medical manufactures its devices in accordance with current Good Manufacturing Practices (cGMP) and markets them directly to hospitals, endoscopy centers and ambulatory surgical facilities across the United States. In addition to in-house sales, the company pursues strategic partnerships and licensing agreements to integrate its insufflation technology into third-party endoscopy platforms. Founded in 2013 and headquartered in Tulsa, Oklahoma, CVR Medical remains focused on expanding clinical adoption of its gas-based systems and advancing its research pipeline. The company collaborates with key opinion leaders in gastroenterology to gather real-world data and explore additional applications of its technology. CVR Medical is led by a management team with expertise in medical device development, regulatory affairs and commercialization, aiming to address unmet needs in gastrointestinal diagnostics and therapeutics.AI Generated. May Contain Errors. Read More Receive CRRVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVR Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRRVF Stock News HeadlinesCVR Medical Corp. (CRRVF)August 18, 2024 | nz.finance.yahoo.comCVR Energy (NYSE:CVI) Stock Quotes, Forecast and News SummaryJuly 26, 2024 | benzinga.comOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including power consumption for 1 million GPUs, a cost that rivals entire cities. That disclosure will name the supplier. One small, publicly traded power infrastructure company sits at the center of this - carrying a $1.5 billion backlog and priced like a utility. Dylan Jovine has the full breakdown.June 10 at 1:00 AM | Behind the Markets (Ad)CVR Partners: Lower Distributions, But Undervalued Compared To Its Peers (Rating Downgrade)August 29, 2023 | msn.comCVR Medical Corp (CVMh)July 21, 2023 | investing.comCVR Medical Corp. Announces Amended Restructuring Agreement with CVR Global, Inc.December 20, 2022 | finance.yahoo.comCVR Medical Corp. Announces Completion of 2022 3rd Quarter Financial StatementDecember 1, 2022 | finance.yahoo.comTikToker shares life-saving tip for getting out of a zip tieSeptember 8, 2022 | yahoo.comSee More Headlines CRRVF Stock Analysis - Frequently Asked Questions How do I buy shares of CVR Medical? Shares of CRRVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/10/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MEDICAL INFO SYS Sub-IndustryN/A Current SymbolOTCMKTS:CRRVF CIKN/A Webcvrmed.com Phone(734) 718-5115FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta31.82 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:CRRVF) was last updated on 6/10/2026 by MarketBeat.com Staff. From Our PartnersHe Called NVIDIA at $1.10 – Now He Says, “SELL”The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...The Oxford Club | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...Porter & Company | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredTesla. SolarCity. Twitter. This $4 stock is next.Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVR Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVR Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.